Literature DB >> 9555869

Lysophosphatidylcholine is involved in the antigenicity of oxidized LDL.

R Wu1, Y H Huang, L S Elinder, J Frostegård.   

Abstract

Lysophosphatidylcholine (LPC) is formed by hydrolysis of PC in low density lipoprotein (LDL) and cell membranes by phospholipase A2 or by oxidation. Oxidized (ox) LDL activates endothelial cells, an effect mimicked by LPC. oxLDL also has the capacity to activate T and B cells, and antibody titers to oxLDL are related to the degree of atherosclerosis. The antigen in oxLDL responsible for its immune-stimulatory capacity is not well characterized, and we hypothesized that LPC was involved. We demonstrate herein the presence of antibodies against LPC, both of the IgG and IgM isotype, in 210 healthy individuals. This antibody reactivity was not specifically related to oxidation of the fatty acid moiety in LPC, since LPC containing only palmitic acid showed antibody titers equivalent to those of LPC containing unsaturated fatty acids. Antibody titers to PC were low compared with LPC, and hydrolysis of PC at the sn-2 position is thus essential for immune reactivity. There was a close correlation between anti-oxLDL and anti-LPC antibodies. Furthermore, LPC competitively inhibited anti-oxLDL reactivity, which indicates that LPC may explain a significant part of the immune-stimulatory properties of oxLDL. LPC, being a lipid, is not likely to be an antigen itself. Instead, LPC could form immunogenic complexes with peptides, which may induce and potentiate immune reactions in the vessel wall. This study adds to the evidence that LPC is an important component of oxLDL and emphasizes the potential role of phospholipase A2 in atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9555869     DOI: 10.1161/01.atv.18.4.626

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  19 in total

1.  Inflammation-mediated rheumatic diseases and atherosclerosis.

Authors:  S Manzi; M C Wasko
Journal:  Ann Rheum Dis       Date:  2000-05       Impact factor: 19.103

Review 2.  Oxidative stress in systemic lupus erythematosus and antiphospholipid syndrome: a gateway to atherosclerosis.

Authors:  José Delgado Alves; Bruno Grima
Journal:  Curr Rheumatol Rep       Date:  2003-10       Impact factor: 4.592

Review 3.  Atherogenesis and the humoral immune response to modified lipoproteins.

Authors:  Gabriel Virella; Maria F Lopes-Virella
Journal:  Atherosclerosis       Date:  2008-04-12       Impact factor: 5.162

4.  Metabolomic characterization of hypertension and dyslipidemia.

Authors:  Chaofu Ke; Xiaohong Zhu; Yuxia Zhang; Yueping Shen
Journal:  Metabolomics       Date:  2018-08-31       Impact factor: 4.290

5.  Lysophosphatidylcholine (LPC) induces proinflammatory cytokines by a platelet-activating factor (PAF) receptor-dependent mechanism.

Authors:  Y H Huang; L Schäfer-Elinder; R Wu; H E Claesson; J Frostegård
Journal:  Clin Exp Immunol       Date:  1999-05       Impact factor: 4.330

6.  Antibodies to adult human endothelial cells cross-react with oxidized low-density lipoprotein and beta 2-glycoprotein I (beta 2-GPI) in systemic lupus erythematosus.

Authors:  R Wu; E Svenungsson; I Gunnarsson; C Haegerstrand-Gillis; B Andersson; I Lundberg; L S Elinder; J Frostegård
Journal:  Clin Exp Immunol       Date:  1999-03       Impact factor: 4.330

7.  Formation of transient non-protein calcium pores by lysophospholipids in S49 Lymphoma cells.

Authors:  H A Wilson-Ashworth; A M Judd; R M Law; B D Freestone; S Taylor; M K Mizukawa; K R Cromar; S Sudweeks; J D Bell
Journal:  J Membr Biol       Date:  2004-07-01       Impact factor: 1.843

Review 8.  Clinical significance of the humoral immune response to modified LDL.

Authors:  Maria F Lopes-Virella; Gabriel Virella
Journal:  Clin Immunol       Date:  2009-05-08       Impact factor: 3.969

9.  Effects of sodium nitrite supplementation on vascular function and related small metabolite signatures in middle-aged and older adults.

Authors:  Allison E DeVan; Lawrence C Johnson; Forrest A Brooks; Trent D Evans; Jamie N Justice; Charmion Cruickshank-Quinn; Nichole Reisdorph; Nathan S Bryan; Matthew B McQueen; Jessica R Santos-Parker; Michel B Chonchol; Candace J Bassett; Amy L Sindler; Tony Giordano; Douglas R Seals
Journal:  J Appl Physiol (1985)       Date:  2015-11-25

10.  Metabolomics reveals that hepatic stearoyl-CoA desaturase 1 downregulation exacerbates inflammation and acute colitis.

Authors:  Chi Chen; Yatrik M Shah; Keiichirou Morimura; Kristopher W Krausz; Makoto Miyazaki; Terrilyn A Richardson; Edward T Morgan; James M Ntambi; Jeffrey R Idle; Frank J Gonzalez
Journal:  Cell Metab       Date:  2008-02       Impact factor: 27.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.